Your browser doesn't support javascript.
loading
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma.
Hanna, Glenn J; Ahn, Myung-Ju; Muzaffar, Jameel; Keam, Bhumsuk; Bowles, Daniel W; Wong, Deborah J; Ho, Alan L; Kim, Sung-Bae; Worden, Francis; Yun, Tak; Meng, Xianzhang; Van Tornout, Jan M; Conlan, Maureen G; Kang, Hyunseok.
Affiliation
  • Hanna GJ; Dana-Farber Cancer Institute, Center for Salivary and Rare Head and Neck Cancers, Boston, Massachusetts.
  • Ahn MJ; Samsung Medical Center, Department of Hematology and Oncology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Muzaffar J; Moffitt Cancer Center, Department of Head and Neck-Endocrine Oncology, Tampa, Florida.
  • Keam B; Seoul National University Hospital, College of Medicine, Seoul, Republic of Korea.
  • Bowles DW; Department of Medicine-Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Wong DJ; Department of Head and Neck Medical Oncology, University of California, Los Angeles (UCLA), Los Angeles, California.
  • Ho AL; Department of Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
  • Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Worden F; Rogel Cancer Center, Michigan Medicine at the University of Michigan, Ann Arbor, Michigan.
  • Yun T; National Cancer Center, Goyang, Republic of Korea.
  • Meng X; Elevar Therapeutics, Fort Lee, New Jersey.
  • Van Tornout JM; Elevar Therapeutics, Fort Lee, New Jersey.
  • Conlan MG; Elevar Therapeutics, Fort Lee, New Jersey.
  • Kang H; Department of Oncology University of California, San Francisco (UCSF), San Francisco, California.
Clin Cancer Res ; 29(22): 4555-4563, 2023 11 14.
Article in En | MEDLINE | ID: mdl-37643133

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Adenoid Cystic / Antineoplastic Agents Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Adenoid Cystic / Antineoplastic Agents Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article